Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1416 clinical trials
Radiomics Tool for Pulmonary Nodule Risk Stratification

Final pulmonary nodule diagnosis will be categorized as malignant or benign. If the pathology report does not offer a specific pathologic diagnosis or is inconclusive (i.e., the biopsy was non-diagnostic), we will define pulmonary nodule resolution, shrinkage, or diameter stability at 12 months as a benign diagnosis.

  • 0 views
  • 11 Jul, 2024
  • 1 location
Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

This study aims to collect convalescent plasma and use it as experimental treatment in critically ill Covid-19 patients in order to reduce mortality and length of stay in intensive care unit.

mechanical ventilation
critical illness
covid-19
organ failure
acute respiratory distress
  • 0 views
  • 05 Aug, 2020
Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture

The objective of this trial will be to establish whether the ultrasound-guided suprainguinal fascia iliaca compartment block is capable of protecting geriatric patients with hip fracture from delirium as compared to placebo

delirium
ache
ropivacaine
hip fracture
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tofacitinib for Immune Skin Conditions in Down Syndrome

Investigators will also measure the impact of interferon inhibition on a variety of molecular markers, as well as the cognitive abilities and quality of life of participants.

antibiotics
vitiligo
skin disorder
hidradenitis
atopic dermatitis
  • 0 views
  • 16 Feb, 2024
  • 1 location
Suicide Prevention for Patients With Chronic Pain

We have used an adaptive design so that if there is strong evidence for target engagement, we will continue with the trial as a fully powered clinical trial (i.e., the end of the current proposal will act as the interim assessment) to the determine the efficacy of remote PST for …

chronic pain
suicidal
suicide prevention
amplified musculoskeletal pain syndrome
chronic widespread pain
  • 0 views
  • 16 Feb, 2024
  • 1 location
Hyperpolarized Imaging for New Treatments

The introduction of triple combination CFTR modulator therapy for patients with Cystic Fibrosis (CF) with at least one copy of the deltaF508 mutation is expected to provide major health benefits, but will also require novel outcome measures that can detect CF lung disease at an early stage, capture the efficacy …

antibiotics
multiple breath washout
sweat test
sweat chloride test
cystic fibrosis
  • 0 views
  • 16 Feb, 2024
  • 4 locations
CO2 Laser Revision for Burn Related Donor Site Scars

These will be prospectively observed for the duration of the study as well as adjacent normal skin. In addition, a donor site that meets inclusion criteria that would not have otherwise received LSR will be identified as a treatment site.

third degree burn
laser therapy
occupational therapies
scarring
compression therapy
  • 0 views
  • 05 Aug, 2020
Resilience-Based Diabetes Self-Management Education (RB-DSME) for African Americans

African Americans are twice as likely to have type 2 diabetes as non-Hispanic Whites and are less likely to engage in effective diabetes self-management. There is a critical need for intensive lifestyle interventions that address the distress inherent in having the disease and the unique stressors faced by African Americans …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

metastatic hepatocellular carcinoma
cancer
carcinoma
liver cancer
hepatocellular carcinoma
  • 0 views
  • 05 Aug, 2020
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

An open-label multi-center phase Ib/II study to evaluate the efficacy and safety of anti-PD-1/CTLA-4 bispecific antibody AK104 plus lenvatinib as the first-line therapy for patients with advanced hepatocellular carcinoma.

measurable disease
hepatocellular carcinoma
lenvatinib
carcinoma
  • 0 views
  • 05 Aug, 2020